Can a new anesthetic shield elderly hearts during surgery?

NCT ID NCT07725185

ENROLLING_BY_INVITATION Disease control Sponsor: Affiliated Hospital of Jiaxing University Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial compares two anesthetic drugs—remimazolam and propofol—to see which one better protects the heart in elderly patients undergoing general anesthesia. Researchers will measure heart function and levels of a heart injury marker after surgery. The goal is to find out if remimazolam can reduce the risk of postoperative heart damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: remimazolam or propofol, two anesthetic drugs given intravenously during surgery
What this could lead to: If remimazolam proves better at protecting the heart, it could become a preferred anesthetic for elderly patients undergoing long surgeries.
What could go wrong: This is a small, early-stage trial with 80 participants, so results may not apply broadly. Both drugs have known side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOCARDIAL INJURY

Contacts and locations

Show contact details

Locations

Jiaxing University Affiliated Hospital

Jiaxing, Zhejiang, 314000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.